Abstract

Topical formulations are an important pillar in the therapy of skin diseases. Nevertheless, after application the formulation will be exposed to environmental effects. Contact with other surfaces will reduce the available amount of formulation and drug substance. The resulting consequences for therapy range from reduced effects to therapeutic failure. The removed active ingredient also contaminates patients’ environment. The aim of this work was to develop preparations that remain at the application site. These will enhance safety and efficiency and thus improve of skin disease therapies. Therefore, we developed polymer-stabilised emulsions that show thermogelling properties. Emulsions with different methyl cellulose concentrations and macrogols of different molecular weights were investigated. The dispersed phase consisted of nonivamide as the active pharmaceutical ingredient, dissolved in medium-chain triglycerides. Rheological properties, droplet size, substantivity and ex vivo penetration experiments were performed to characterise the developed formulations. Droplet size and rheological parameters were affected by the composition of the preparations. The tested formulations showed benefits in their substantivity compared to a conventional semi-solid cream. We found a residual amount of up to 100% at the application site. The drug levels in viable epidermis were in a therapeutic range. The developed emulsions are a promising vehicle to improve therapy for chronic skin diseases.

Highlights

  • The vehicle of a topical formulation plays an important role with respect to disease control and therapeutic outcome

  • We focus on nonivamide as a drug substance for chronic skin diseases

  • We investigated the effect of different methyl cellulose concentrations and different macrogol types on rheological properties and substantivity

Read more

Summary

Introduction

The vehicle of a topical formulation plays an important role with respect to disease control and therapeutic outcome It controls the penetration profile of the preparation [1,2,3,4,5] and has an effect on the skin barrier function [6,7]. Topical formulations that are more resistant to contact with the environment and remain at the application site are a promising approach to improve patients’ compliance and reduce the consumption of such formulations. Formulations that remain on the skin surface are possible drug reservoirs for topical preparations that exhibit sustained release

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call